Related references
Note: Only part of the references are listed.Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard
Mina Mirzaian et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Development of an acid ceramidase activity-based probe
Cecile M. J. Ouairy et al.
CHEMICAL COMMUNICATIONS (2015)
Synthesis of a Panel of Carbon-13-Labelled (Glyco)Sphingolipids
Patrick Wisse et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2015)
Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease
Bouwien E. Smid et al.
JOURNAL OF MEDICAL GENETICS (2015)
The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain
L. Choi et al.
NEUROSCIENCE LETTERS (2015)
Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance
B. E. Smid et al.
CLINICAL GENETICS (2015)
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses
Maria J. Ferraz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Prevalence of Fabry's disease within hemodialysis patients in Spain
Julio Herrera et al.
CLINICAL NEPHROLOGY (2014)
An intronic haplotype in α galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke
David A. Zeevi et al.
GENE (2014)
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4+919G > A)
Ting-Rong Hsu et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients
Arndt Rolfs et al.
PLOS ONE (2013)
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Natalia Realini et al.
SCIENTIFIC REPORTS (2013)
Vascular Aspects of Fabry Disease in Relation to Clinical Manifestations and Elevations in Plasma Globotriaosylsphingosine
Saskia M. Rombach et al.
HYPERTENSION (2012)
The cellular pathology of lysosomal diseases
Timothy M. Cox et al.
JOURNAL OF PATHOLOGY (2012)
Small fiber neuropathy in Fabry disease
Marieke Biegstraaten et al.
MOLECULAR GENETICS AND METABOLISM (2012)
A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations
Alessio Lodola et al.
PLOS ONE (2012)
Biochemical and Mass Spectrometric Characterization of Human N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition
Jay M. West et al.
PLOS ONE (2012)
Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy
Marielle J. van Breemen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
Nick Dekker et al.
BLOOD (2011)
Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
S. M. Rombach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Ultrasensitive in situ visualization of active glucocerebrosidase molecules
Martin D. Witte et al.
NATURE CHEMICAL BIOLOGY (2010)
Obesity in Elderly Subjects In sheep's clothing perhaps, but still a wolf!
Etty Osher et al.
DIABETES CARE (2009)
Autoproteolytic cleavage and activation of human acid ceramidase
Nataly Shtraizent et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma
Johanna E. M. Groener et al.
CLINICAL CHEMISTRY (2007)
CCL18: A urinary marker of Gaucher cell burden in Gaucher patients
Rolf G. Boot et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product
M Rossocha et al.
BIOCHEMISTRY (2005)
Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis
M Ishibashi et al.
LABORATORY INVESTIGATION (2003)
Share Paper
